Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
B of A Securities analyst Duksan Jang downgrades Axcelis Technologies (NASDAQ:ACLS) from Neutral to Underperform and raises ...
Analyst takes cautious stance on ACLS, cuts rating to Underperform and raises price forecast due to potential of merger with VE...
Berkshire agreed to buy OxyChem for $9.7 billion while EA goes private for $55 billion. Also, Middleby seeks a $800 million deal.
DA Davidson analyst Thomas Diffely maintains Axcelis Technologies (NASDAQ:ACLS) with a Buy and raises the price target from ...
When markets hit new all-time highs and every asset class seems to be joining the party, it could be the perfect time to sell.
Benchmark analyst Mark Miller upgrades Axcelis Technologies (NASDAQ:ACLS) from Hold to Buy and announces $105 price target.
